Browse studies
Find your next paid study
2 recruiting studies matching your filters
Phase 1
A Phase I/IIa, Open-Label, Dose Escalation Study to Evaluate the Safety and Tolerability of HiCM-188, an Allogeneic iPSC-derived Cardiomyocyte Therapy, in Adult Patients With Advanced Heart Failure
This clinical study will evaluate the safety and tolerability of HiCM-188, an investigational allogeneic induced pluripotent stem cell (iPSC)-derived cardiomyo…
Advanced Heart FailureIschemic Heart Failure
Estimated
~$10 – $8,750
HELP Therapeutics Co., Ltd.NCT07646210
Observational
Randomized Controlled Pivotal Trial of Autologous Bone Marrow Mononuclear Cells Using the CardiAMP Cell Therapy System in Patients With Ischemic Heart Failure II Trial
Concentrated autologous bone marrow mononuclear cells (ABM MNC) contain potentially therapeutic cell factors and past studies support therapeutic benefit to pa…
Ischemic Heart Failure
Estimated
~$10 – $8,750
BioCardia, Inc.NCT06258447